Locoregional radioimmunotherapy in selected patients with malignant glioma: experiences, side effects and survival times. (Q48294819)

10 February 2018

title

Locoregional radioimmunotherapy in selected patients with malignant glioma: experiences, side effects and survival times. (English)

1 reference

10 February 2018

author name string

C Goetz

1

1 reference

10 February 2018

P Riva

2

1 reference

10 February 2018

G Poepperl

3

1 reference

10 February 2018

F J Gildehaus

4

1 reference

10 February 2018

A Hischa

5

1 reference

10 February 2018

K Tatsch

6

1 reference

10 February 2018

H J Reulen

7

1 reference

10 February 2018

publication date

1 May 2003

1 reference

10 February 2018

Journal of Neuro-Oncology

published in

1 reference

10 February 2018

volume

62

1 reference

10 February 2018

issue

3

1 reference

10 February 2018

page(s)

321-328

1 reference

10 February 2018

https://scigraph.springernature.com/pub.10.1023/a:1023309927635

exact match

0 references

cites work

Stereotactic administration of intratumoral chronic chemotherapy of recurrent malignant gliomas.

1 reference

12 December 2020

Gene therapy of malignant glioma: recent advances in experimental and clinical studies

1 reference

12 December 2020

Interstitial chemotherapy with sustained-release polymer systems for the treatment of malignant gliomas

1 reference

12 December 2020

Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials.

1 reference

12 December 2020

Stereotactic radiosurgery for recurrent gliomas

1 reference

12 December 2020

Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: phase I trial results

1 reference

12 December 2020

Intrathecal 131I-labeled antitenascin monoclonal antibody 81C6 treatment of patients with leptomeningeal neoplasms or primary brain tumor resection cavities with subarachnoid communication: phase I trial results

1 reference

12 December 2020

Phase I/II clinical radioimmunotherapy with an iodine-131-labeled anti-carcinoembryonic antigen murine monoclonal antibody IgG

1 reference

12 December 2020

Quality-adjusted survival analysis of malignant glioma. Patients treated with twice-daily radiation (RT) and carmustine: a report of Radiation Therapy Oncology Group (RTOG) 83-02.

1 reference

12 December 2020

Expression of tenascin-C in astrocytic tumors: its relevance to proliferation and angiogenesis.

1 reference

12 December 2020

Therapy for patients with high grade astrocytoma using intraarterial chemotherapy and radiation therapy.

1 reference

12 December 2020

Phase I trial results of iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with newly diagnosed malignant gliomas.

1 reference

12 December 2020

Expression of adhesion molecules and extracellular matrix proteins in glioblastomas: relation to angiogenesis and spread

1 reference

12 December 2020

Malignant glioma: who benefits from adjuvant chemotherapy?

1 reference

12 December 2020

Loco-regional radioimmunotherapy of high-grade malignant gliomas using specific monoclonal antibodies labeled with 90Y: a phase I study.

1 reference

12 December 2020

Treatment of malignant glioma: a problem beyond the margins of resection

1 reference

12 December 2020

Local treatment of malignant gliomas by direct infusion of specific monoclonal antibodies labeled with 131I: comparison of the results obtained in recurrent and newly diagnosed tumors.

1 reference

12 December 2020

Malignant astrocytomas treated with iodine-125 labeled monoclonal antibody 425 against epidermal growth factor receptor: A phase II trial

1 reference

12 December 2020

A phase I escalating-dose safety, dosimetry and efficacy study of radiolabeled monoclonal antibody LYM-1.

1 reference

12 December 2020

Expression of different extracellular matrix components in human brain tumor and melanoma cells in respect to variant culture conditions

1 reference

12 December 2020

Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms.

1 reference

12 December 2020

Thymidine kinase gene therapy for human malignant glioma, using replication-deficient retroviruses or adenoviruses

1 reference

12 December 2020

Dosimetry and dose-response relationships in newly diagnosed patients with malignant gliomas treated with iodine-131-labeled anti-tenascin monoclonal antibody 81C6 therapy

1 reference

12 December 2020

Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma.

1 reference

12 December 2020

Interstitial chemotherapy with mitoxantrone in recurrent malignant glioma: preliminary data

1 reference

12 December 2020

Comparison of serial PET and MRI scans in a pediatric patient with a brainstem glioma.

1 reference

12 December 2020

Phase I studies of treatment of malignant gliomas and neoplastic meningitis with 131I-radiolabeled monoclonal antibodies anti-tenascin 81C6 and anti-chondroitin proteoglycan sulfate Me1-14 F (ab')2--a preliminary report

1 reference

12 December 2020

Chemotherapy of brain tumors

1 reference

12 December 2020

The distribution of extracellular matrix proteins and CD44S expression in human astrocytomas.

1 reference

12 December 2020

Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms.

1 reference

12 December 2020

The limits of treatment of malignant gliomas

1 reference

12 December 2020

Role of nuclear medicine in the treatment of malignant gliomas: the locoregional radioimmunotherapy approach

1 reference

12 December 2020

A phase I dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma.

1 reference

12 December 2020

Regrowth patterns of glioblastoma multiforme related to planning of interstitial brachytherapy radiation fields.

1 reference

12 December 2020

Gene therapy for malignant gliomas

1 reference

12 December 2020

Morbidity and survival after 1,3-bis(2-chloroethyl)-1-nitrosourea wafer implantation for recurrent glioblastoma: a retrospective case-matched cohort series.

1 reference

12 December 2020

Biology and treatment of malignant glioma

1 reference

12 December 2020

Malignant glioma: who benefits from adjuvant chemotherapy?

1 reference

12 December 2020

Response of recurrent glioblastoma and anaplastic astrocytoma to dibromodulcitol, BCNU and procarbazine--a phase-II study.

1 reference

12 December 2020

Distribution and dosimetry of I-123-labeled monoclonal antibody 81C6 in patients with anaplastic glioma.

1 reference

12 December 2020

Initial experiences with adjuvant locoregional radioimmunotherapy using 131I-labeled monoclonal antibodies against tenascin (BC-4) for treatment of glioma (WHO III and IV)

1 reference

12 December 2020

Prognostic factors in high-grade malignant glioma. A multivariate analysis of 76 cases with postoperative radiotherapy.

1 reference

12 December 2020

Survival results from a phase I study of etanidazole (SR2508) and radiotherapy in patients with malignant glioma.

1 reference

12 December 2020

Phase I/II radioimmunotherapy trial with iodine-131-labeled monoclonal antibody G250 in metastatic renal cell carcinoma

1 reference

12 December 2020

Stereotactic radiosurgery as an adjunct to surgery and external beam radiotherapy in the treatment of patients with malignant gliomas

1 reference

12 December 2020

Extirpation of glioblastomas: MR and CT follow-up of residual tumor and regrowth patterns.

1 reference

12 December 2020

131I radioconjugated antibodies for the locoregional radioimmunotherapy of high-grade malignant glioma--phase I and II study

1 reference

12 December 2020

Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991.

1 reference

12 December 2020

Radionecrosis secondary to interstitial brachytherapy: correlation of magnetic resonance imaging and histopathology

1 reference

12 December 2020

Multivariate analysis of prognostic factors in 106 patients with malignant glioma.

1 reference

12 December 2020

Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group

1 reference

12 December 2020

Identification of a glioblastoma-associated tenascin-C isoform by a high affinity recombinant antibody

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1023309927635

1 reference

10 February 2018

Dimensions Publication ID

0 references

1 reference

10 February 2018